Pilot Intervention to Improve Medication Adherence Among Patients With Systemic Lupus Erythematosus Using Pharmacy Refill Data.


Journal

Arthritis care & research
ISSN: 2151-4658
Titre abrégé: Arthritis Care Res (Hoboken)
Pays: United States
ID NLM: 101518086

Informations de publication

Date de publication:
03 2023
Historique:
revised: 07 09 2021
received: 25 06 2021
accepted: 12 10 2021
pmc-release: 01 03 2024
pubmed: 6 11 2021
medline: 25 2 2023
entrez: 5 11 2021
Statut: ppublish

Résumé

Despite high rates of medication nonadherence among patients with systemic lupus erythematosus (SLE), effective interventions to improve adherence in SLE are limited. We aimed to assess the feasibility of a pilot intervention and explore its effect on adherence. The intervention used pharmacy refill data to monitor nonadherence and prompt discussions surrounding SLE medications during clinic encounters. Over 12 weeks, the intervention was delivered through routine clinic visits by providers to patients with SLE who take SLE-specific medications. We measured acceptability, appropriateness, and feasibility using provider surveys. We also measured acceptability by patient surveys and feasibility by medical record documentation. We explored change in adherence by comparing percent of patients with medication possession ratio (MPR) ≥80% 3 months before and after the intervention visit using the McNemar's test. Six rheumatologists participated; 130 patients were included in the analysis (median age 43, 95% female, and 59% racial and ethnic minorities). Implementation of the intervention was documented in 89% of clinic notes. Provider surveys showed high scores for feasibility (4.7/5), acceptability (4.4/5), and appropriateness (4.6/5). Among patient surveys, the most common reactions to the intervention visit were feeling determined (32%), empowered (32%), and proud (19%). Proportion of patients with MPR ≥80% increased from 48% to 58% (P = 0.03) after the intervention visit. Our intervention showed feasibility, acceptability, and appropriateness and led to a statistically significant improvement in adherence. Future work should refine the intervention, assess its efficacy in a controlled setting, and adapt its use among other clinic settings.

Identifiants

pubmed: 34739191
doi: 10.1002/acr.24806
pmc: PMC9068832
mid: NIHMS1749044
doi:

Banques de données

ClinicalTrials.gov
['NCT03738826']

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

550-558

Subventions

Organisme : NCATS NIH HHS
ID : KL2 TR002554
Pays : United States
Organisme : NIMHD NIH HHS
ID : U54 MD012530
Pays : United States

Informations de copyright

© 2021 American College of Rheumatology.

Références

J Rheumatol. 2021 Jul;48(7):1022-1028
pubmed: 33259332
J Rheumatol. 2015 Nov;42(11):2092-7
pubmed: 26428205
J Gen Intern Med. 2016 Aug;31(8):929-40
pubmed: 27160414
Arthritis Care Res (Hoboken). 2021 Nov;73(11):1561-1567
pubmed: 32741110
Patient Prefer Adherence. 2017 Jul 14;11:1213-1219
pubmed: 28761334
Joint Bone Spine. 2020 Dec;87(6):603-610
pubmed: 32438061
Arthritis Rheum. 1997 Sep;40(9):1725
pubmed: 9324032
Curr Rheumatol Rev. 2020;16(3):245-248
pubmed: 31241434
J Rheumatol. 2012 Jan;39(1):174-9
pubmed: 22089460
Rheumatology (Oxford). 2018 Oct 1;57(10):1743-1751
pubmed: 29931367
Ann Rheum Dis. 2016 Apr;75(4):667-73
pubmed: 25667208
RMD Open. 2018 Jul 27;4(2):e000684
pubmed: 30116556
Arthritis Care Res (Hoboken). 2018 Sep;70(9):1400-1405
pubmed: 28575545
Rheumatol Adv Pract. 2021 Jan 24;5(1):rkaa078
pubmed: 33604502
Implement Sci. 2017 Aug 29;12(1):108
pubmed: 28851459
J Rheumatol. 2019 Oct;46(10):1309-1315
pubmed: 30709949
Rheumatology (Oxford). 2020 Dec 1;59(12):3622-3632
pubmed: 32789462
Ann Rheum Dis. 2021 Jun;80(6):707-713
pubmed: 33355152
RMD Open. 2020 Nov;6(3):
pubmed: 33161377
Semin Arthritis Rheum. 2018 Oct;48(2):205-213
pubmed: 29458974
Arthritis Care Res (Hoboken). 2022 Sep;74(9):1459-1467
pubmed: 33662174
ACR Open Rheumatol. 2020 Jul;2(7):430-437
pubmed: 32584516
Arthritis Care Res (Hoboken). 2017 Nov;69(11):1706-1713
pubmed: 28086003
Clin Pharmacol Ther. 2019 Aug;106(2):374-382
pubmed: 30079582
Arthritis Rheum. 2012 Aug;64(8):2677-86
pubmed: 22553077
J Clin Rheumatol. 2008 Aug;14(4):195-201
pubmed: 18636020
Pediatr Rheumatol Online J. 2018 Mar 14;16(1):18
pubmed: 29540181
Arthritis Rheum. 1996 Mar;39(3):363-9
pubmed: 8607884
Pediatr Rheumatol Online J. 2020 Apr 26;18(1):36
pubmed: 32340616
Rheumatology (Oxford). 2009 Mar;48(3):266-71
pubmed: 19151034
Rheumatology (Oxford). 2007 Jun;46(6):895-8
pubmed: 17307754
Best Pract Res Clin Rheumatol. 2013 Jun;27(3):329-40
pubmed: 24238690
Arthritis Care Res (Hoboken). 2015 Dec;67(12):1712-21
pubmed: 26097166
J Pediatr. 2012 Oct;161(4):695-9.e1
pubmed: 22608905
Ann Rheum Dis. 2007 Jun;66(6):821-4
pubmed: 17324970
Arthritis Care Res (Hoboken). 2019 Nov;71(11):1419-1424
pubmed: 30354025
Lupus. 2003;12(4):280-6
pubmed: 12729051

Auteurs

Kai Sun (K)

Duke University School of Medicine, Durham, North Carolina.

Amanda M Eudy (AM)

Duke University School of Medicine, Durham, North Carolina.

Jennifer L Rogers (JL)

Duke University School of Medicine, Durham, North Carolina.

Lisa G Criscione-Schreiber (LG)

Duke University School of Medicine, Durham, North Carolina.

Rebecca E Sadun (RE)

Duke University School of Medicine, Durham, North Carolina.

Jayanth Doss (J)

Duke University School of Medicine, Durham, North Carolina.

Mithu Maheswaranathan (M)

Duke University School of Medicine, Durham, North Carolina.

Ann Cameron Barr (AC)

Duke University School of Medicine, Durham, North Carolina.

Lena Eder (L)

Duke University School of Medicine, Durham, North Carolina.

Amy L Corneli (AL)

Duke University School of Medicine, Durham, North Carolina.

Hayden B Bosworth (HB)

Duke University School of Medicine, Durham, North Carolina.

Megan E B Clowse (MEB)

Duke University School of Medicine, Durham, North Carolina.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH